Irritable bowel syndrome (IBS) has long been a diagnosis of exclusion - doctors rule out a number of other conditions before they can say it's IBS.

That's because there haven't been reliable biomarkers to flag it. But a new analysis from researchers at the University of Newcastle suggests there may in fact be a number of biomarkers associated with IBS.

Guest

• Dr Grace Burns, Postdoctoral Researcher in Immunology and Microbiology, Centre for Research Excellence in Digestive Health, University of Newcastle

References

• Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis